[Ip-health] MSF Access Campaign Executive Director steps down

Joanna Keenan joanna.l.keenan at gmail.com
Tue May 24 01:06:10 PDT 2016

*Médecins Sans Frontières Access Campaign Executive Director steps down*

*Interim Executive Director appointed ahead of search for permanent


*Geneva, 24 May 2016* – After four years at the helm of Médecins Sans
Frontières’ advocacy and campaigning unit, the Access Campaign, Dr Manica
Balasegaram will step down from his position of Executive Director at the
end of May.

Dr Balasegaram will leave the Access Campaign having overseen a team of
people who have worked on lowering the price of vaccines through the Fair
Shot campaign, on improving access for drugs and diagnostics to manage
hepatitis C, TB and HIV, and on highlighting the need to fix our current
system of research and development for new drugs and diagnostics. Dr
Balasegaram has also been involved in important health policy discussions
around AMR, emerging infectious diseases and on access to medicines more
broadly, including being part of the Expert Advisory group for the UN High
Level Panel on Access to Medicines.

Dr Balasegaram will be joining the Global Antibiotic Research and
Development (GARD) Partnership, an initiative spearheaded by Drugs for
Neglected Diseases *initiative* and World Health Organization to develop
new antibiotic treatments and to promote their responsible use, while
ensuring access for all in need. He will take up this new post in early

Ahead of a search for a permanent replacement for Dr Balasegaram, MSF has
appointed Sophie Delaunay as interim Executive Director. Ms Delaunay was
the former Executive Director of MSF USA and currently heads MSF’s effort
to advance knowledge sharing on Ebola and emerging pathogens. She will
serve in this interim role for the next six months, based between MSF’s
Geneva and New York offices.

- Ends -

Joanna Keenan
Press Officer
Médecins Sans Frontières - Access Campaign
P: +41 22 849 87 45
M: +41 79 203 13 02
E: joanna.keenan[at]geneva.msf.org
T: @joanna_keenan


More information about the Ip-health mailing list